Humana Inc. HUM recently inked a new deal with market-leading renal care company Fresenius Medical Care North America (FMCNA). The agreement is to strengthen their partnership for better health outcomes of qualified Humana Medicare Advantage and commercial members with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Members will now be able to enjoy a comprehensive, holistic medical care. The deal will be effective Jan 1, 2021.

The tie-up is expanded considering the goals outlined in the 21st Century Cures Act, according to which patients with ESRD are able to enrol in the Medicare Advantage plans and with federal initiatives that require fast diagnosis and treatment of kidney disease, decline in American patients with ESRD and support for treatment options.

Per the old deal, FMCNA offers specialized care coordination services for Humana members with CKD in Iowa, Kentucky and North Carolina. But the recently signed deal boosts the